Tirzepatide
HealthFirst head-to-head trial compares tirzepatide and semaglutide – Results are in!
The study involved 751 adults with obesity but no type 2 diabetes. The participants were randomly assigned to take either tirzepatide or semaglutide.
Joshua Shavit
